Research Article
Follow-Up of High-Grade Glial Tumor; Differentiation of Posttreatment Enhancement and Tumoral Enhancement by DCE-MR Perfusion
Table 2
Mean and Std deviation of DCE-MRP metrics measured from PT, NNA, and CLNA are given.
| T1 DCE MRP metrics | Mean | Std. Deviation |
| pt ktrans | 0.01 | 0.00 | CLNA ktrans | 0.01 | 0.01 | pt kep | 0.44 | 0.33 | CLNA kep | 1.56 | 1.38 | pt ve | 0.21 | 0.13 | CLNA ve | 0.06 | 0.05 | pt IAUC | 1.69 | 0.39 | CLNA IAUC | 0.55 | 0.55 | pt ktrans | 0.01 | 0.00 | NNA ktrans | 0.01 | 0.01 | pt kep | 0.44 | 0.34 | NNA kep | 1.88 | 1.52 | pt ve | 0.23 | 0.11 | NNA ve | 0.07 | 0.06 | pt IAUC | 1.49 | 0.45 | NNA IAUC | 0.80 | 0.57 |
|
|